Arbutus Biopharma Corp Quarterly Deferred Tax Assets, Operating Loss Carryforwards in CAD from Q4 2011 to Q4 2012
-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Arbutus Biopharma Corp quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2011 to Q4 2012.
- Arbutus Biopharma Corp Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2012 was CA$4.54M, a 2.25% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (CAD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)